Skip to content

Training programme with cachexia risk patients under ongoing oncological systemic therapy

Training programme with cachexia risk patients under ongoing oncological systemic therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00023275
Enrollment
150
Registered
2020-10-27
Start date
2021-04-19
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C14 C15 C16 C25 C34 C32 C30 C31 C81 C82 C83 C84 C85

Interventions

Group 1: combined training programme over 12 weeks 2x/w supervises Hypertrohpie strength training plus endurance training Bicycle ergometer in the continuous method 20-30min with at least 2 days break

Sponsors

Universitätsklinikum Köln
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Oncological disease with diagnosis of (stages 1-4): -pancreatic carcinoma, -Bronchial carcinoma, -ent caricnoma -esophageal carcinoma -stomach carcinoma -malignant lymphomas - Metastatic or non-metastatic - No cachexia or cachexia with 5% weight loss in the last 6 months - Neo-adjuvant or adjuvant systemic therapy (chemo- or immunotherapy) and/or radiotherapy - 10 weeks after cancer diagnosis

Exclusion criteria

Exclusion criteria: -only surgery or only radiotherapy

Design outcomes

Primary

MeasureTime frame
Body weight and bmi T1 12 weeks post- testing T2 12 weeks follow up T3 52 weeks follow up

Secondary

MeasureTime frame
Functional testing - Muscle strength of upper extremities (HandGrip test) - Endurance performance (bicycle ergometer 30/15 test [Spiro]) - Body composition (bio-impedance analysis, mobile device: DataInput) - Power hand grip, leg press (Isokinet) Questionnaire - FAACT (Cachexia) - Subjective physical activity level (BSA) - Quality of Life (EORTC QLQ C30) - Fatigue (MFI20) -HADS blood count, albumin, total protein, CRP, CK

Countries

Germany

Contacts

Public ContactLéa Mazot

Uniklinik Köln

lea.mazot@uk-koeln.de+491632347452

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026